I'm pretty sure someone has posted about this before however I came across it again and this article is from 2016. I can't find a lot of information on the results of studies however they're looking further into the use of cobra venom as a treatment.
I have a contact here in Canada that I dealt with years ago who was fighting to get approval from Health Canada to get the IV version approved for a terminally ill MS patient, however was not able to as there was too much red tape. I'm actually picking up a case of the Nyloxin spray which is similar however not as potent as RPI-78M, which Receptopharm is developing- and is actually now administered orally.